Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus Vaccine

On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 do...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 2007-01, Vol.119 (1), p.171-181
1. Verfasser:	Pickering, Larry K
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Babies Biological and medical sciences Complications and side effects Dosage and administration Feces - virology Gastroenteritis - prevention & control Gastroenteritis - virology General aspects Humans Immunization Immunization Schedule Immunocompromised Host Infant Infant, Newborn Infant, Premature Medical sciences Miscellaneous Pediatrics Practice guidelines (Medicine) Prevention Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Risk Factors Rotavirus Rotavirus - isolation & purification Rotavirus infections Rotavirus Infections - epidemiology Rotavirus Infections - prevention & control Rotavirus Vaccines - administration & dosage Rotavirus Vaccines - adverse effects Rotavirus Vaccines - immunology United States - epidemiology Vaccines Vaccines, Attenuated - administration & dosage Vaccines, Attenuated - adverse effects Vaccines, Attenuated - immunology Viral vaccines Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!